Feature
Even minor weight loss is associated with worse health outcomes among patients implanted with a certain type of defibrillator known as cardiac resynchronization therapy with defibrillator (CRT-D), according to research being presented at the American College of Cardiology’s 62nd Annual Scientific Session.
March 11, 2013
Technology
Lumedx unveiled a host of new HealthView products at the American College of Cardiology Scientific Sessions in San Francisco, March 9-11, 2013. New solutions include a comprehensive, Web-based CVIS with numerous newly released and upgraded components.
March 11, 2013
Technology
Siemens Healthcare has announced that the U.S. Food and Drug Administration (FDA) has cleared its Artis Q and Artis Q.zen angiography system families, which feature revolutionary new X-ray tube and detector technology designed to improve minimally invasive therapy of diseases such as coronary artery disease (CAD), stroke and cancer. The new X-ray tube in both the Artis Q and Artis Q.zen can help physicians identify small vessels up to 70 percent better than conventional X-ray tube technology. The Artis Q.zen combines this X-ray source with a new detector technology that supports interventional imaging in ultra-low-dose ranges to patients, doctors and medical staff — particularly during longer interventions. With the Artis Q and Artis Q.zen system families, Siemens Healthcare again demonstrates its innovative strength and market competitiveness — key components of its Agenda 2013 two-year global Sector initiative.
March 11, 2013Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
As cardiologists assemble in San Francisco for the 2013 Scientific Sessions of the American College of Cardiology, they are faced with the challenge of how to handle the high volume of additional patients entering the healthcare system due to the Affordable Care Act.
March 08, 2013Technology
Boston Scientific Corporation has begun the launch of its 0.035-inch and 0.018-inch Rubicon Support Catheter in the United States. The device is designed to assist physicians with placement and support of guidewires that are used in peripheral vascular procedures to deliver stents and balloons to open blockages in the legs and other peripheral arteries. Boston Scientific is also launching the 0.035-inch Rubicon Support Catheter in Europe to build on the momentum of the 0.018-inch size that was introduced in that region last fall.
March 08, 2013
Feature
March 7, 2013 — Ultrasound technology could soon experience a significant upgrade that would enable it to produce high-quality, high-resolution images, thanks to the development of a new key material by a team of researchers that includes a professor in the department of biomedical engineering at Texas A&M University.
March 07, 2013Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
March 7, 2013 — A newly identified genetic variant doubles the risk of calcium buildup in the heart’s aortic valve. Calcium buildup is the most common cause of aortic stenosis, a narrowing of the aortic valve that can lead to heart failure, stroke and sudden cardiac death.
March 07, 2013News
March 7, 2013 — Experts from The Children's Hospital of Philadelphia were among the leaders of two large national studies showing that extending cardiopulmonary resuscitation (CPR) longer than previously thought useful saves lives in both children and adults. The research teams analyzed the impact of CPR duration in patients who suffered cardiac arrest while hospitalized.
March 07, 2013
Technology
MobileDemand and VectraCor Inc. have partnered to provide a turnkey solution to the healthcare industry for patients presenting with chest pain to detect real-time ECG changes suggestive of a heart attack. VectraCor has chosen the xTablet C1200 rugged convertible to use as their mobile, rugged version of the VectraplexECG System.
March 07, 2013Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Feature
The American Society of Echocardiography (ASE) has released a list of five interventions whose appropriateness physicians and patients should discuss as part of Choosing Wisely, an initiative of the ABIM Foundation, along with Consumer Reports. First in the list, they ask that patients and their doctors talk about the real need for additional echocardiograms when there are only minor signs of heart valve leakage.
March 07, 2013
Technology
March 7, 2013 — Philips Healthcare announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its EchoNavigator live image-guidance tool.
March 07, 2013News
CardioNet Inc. announced a multi-year development agreement with the Belgium-based nanoelectronics research center IMEC and its Dutch affiliate Holst Centre. Over the next 18 months, the companies will work to develop two revolutionary cardiac monitoring products.
March 07, 2013Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News
Mercator MedSystems Inc. announced it has received CE mark approval to market its Cricket and Bullfrog Micro-Infusion Catheters in Europe, significantly expanding the market for these products, which have previously received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The Mercator micro-infusion catheters are capable of non-systemic delivery of therapeutic agents directly across any peripheral or coronary blood vessel. Initially, these products will be commercialized for the treatment of peripheral artery disease (PAD), a critical health issue affecting 12-14 percent of the general population and nearly 20 percent of those over the age of 70. Approximately 23 million Western Europeans and 17 million Americans have PAD.
March 07, 2013News
March 7, 2013 — Cardiovascular Systems Inc. (CSI) presented three-year data from its ORBIT I feasibility study of calcified coronary lesions during a poster session at the 2013 Cardiovascular Research Technologies (CRT) conference.
March 07, 2013
Feature
As the U.S. government works to strengthen its global nuclear security strategy by eliminating potential sources of bomb-grade highly enriched uranium (HEU), it has eyed the production of medical isotopes for nuclear imaging, which rely on HEU. To encourage reliable supplies of medical radioisotopes produced from non-HEU sources, President Obama signed into law on Jan. 2, 2013, the American Medical Isotopes Production Act of 2011 (AMIPA). It should be noted that it was part of the 2013 National Defense Authorization Act, so the measure goes beyond interest in just making sure patients have access to radiopharamceutical tracers to enable myocardial perfusion imaging (MPI) scans. The effort is designed to make HEU sources less available on the world market to reduce the threat of nuclear weapons proliferation or the building of a “dirty bomb.”
March 06, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now